Endo International plc (OTC: ENDPQ), an American-Irish specialty pharmaceutical company, announced on Thursday that one of its operating companies, Par Pharmaceutical, Inc, has started shipping colchicine 0.6mg capsules, a generic version of Hikma's MITIGARE.

The product is intended for prophylaxis of gout flares in adults. It is the first generic colchicine capsule approved by the US Food and Drug Administration.

Scott Sims, Endo senior vice president and general manager, Injectable Solutions & Generics, said, 'We are pleased to offer this high-quality, affordable medication. As a reliable supplier of generic products, we take pride in providing choices to appropriate patients.'